C D Pendleton

2.4k total citations
33 papers, 2.1k citations indexed

About

C D Pendleton is a scholar working on Immunology, Virology and Molecular Biology. According to data from OpenAlex, C D Pendleton has authored 33 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Immunology, 23 papers in Virology and 13 papers in Molecular Biology. Recurrent topics in C D Pendleton's work include HIV Research and Treatment (23 papers), Immune Cell Function and Interaction (14 papers) and Immunotherapy and Immune Responses (13 papers). C D Pendleton is often cited by papers focused on HIV Research and Treatment (23 papers), Immune Cell Function and Interaction (14 papers) and Immunotherapy and Immune Responses (13 papers). C D Pendleton collaborates with scholars based in United States, Japan and France. C D Pendleton's co-authors include Jay A. Berzofsky, Mutsunori Shirai, Toshiyuki Takeshita, Richard A. Houghten, Jeffrey D. Ahlers, S M Feinstone, Toshitaka Akatsuka, Ronald N. Germain, David H. Margulies and Mark J. Newman and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

C D Pendleton

33 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C D Pendleton United States	25	1.3k	727	660	510	349	33	2.1k
Peggy Wentworth United States	17	1.3k 1.0×	720 1.0×	320 0.5×	460 0.9×	221 0.6×	23	1.8k
Glenn Ishioka United States	24	1.5k 1.1×	844 1.2×	178 0.3×	591 1.2×	276 0.8×	45	2.3k
Marie‐France del Guercio United States	18	1.3k 1.0×	904 1.2×	346 0.5×	354 0.7×	143 0.4×	21	1.9k
Jonathan Rothbard United Kingdom	11	1.2k 0.9×	816 1.1×	669 1.0×	292 0.6×	206 0.6×	13	2.1k
Denise M. McKinney United States	25	1.1k 0.8×	899 1.2×	300 0.5×	687 1.3×	94 0.3×	32	2.2k
Richard J. Gulizia United States	17	1.3k 1.0×	548 0.8×	1.0k 1.6×	450 0.9×	418 1.2×	22	2.5k
E Gomard France	31	1.9k 1.4×	726 1.0×	986 1.5×	544 1.1×	266 0.8×	69	2.8k
Richard Rudersdorf United States	25	1.4k 1.0×	659 0.9×	813 1.2×	353 0.7×	154 0.4×	32	2.7k
Kent Thudium United States	11	727 0.5×	523 0.7×	183 0.3×	654 1.3×	718 2.1×	11	2.2k

Countries citing papers authored by C D Pendleton

Since Specialization

Citations

This map shows the geographic impact of C D Pendleton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C D Pendleton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C D Pendleton more than expected).

Fields of papers citing papers by C D Pendleton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C D Pendleton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C D Pendleton. The network helps show where C D Pendleton may publish in the future.

Co-authorship network of co-authors of C D Pendleton

This figure shows the co-authorship network connecting the top 25 collaborators of C D Pendleton. A scholar is included among the top collaborators of C D Pendleton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C D Pendleton. C D Pendleton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Huang, Yi‐Hsiang, Masaki Terabe, C D Pendleton, et al.. (2013). Identification and Enhancement of HLA-A2.1-Restricted CTL Epitopes in a New Human Cancer Antigen-POTE. PLoS ONE. 8(6). e64365–e64365. 12 indexed citations

Okazaki, Takahiro, C D Pendleton, Pablo Sarobe, et al.. (2006). Epitope Enhancement of a CD4 HIV Epitope toward the Development of the Next Generation HIV Vaccine. The Journal of Immunology. 176(6). 3753–3759. 10 indexed citations

Oh, SangKon, Brian Stegman, C D Pendleton, et al.. (2006). Protective immunity provided by HLA-A2 epitopes for fusion and hemagglutinin proteins of measles virus. Virology. 352(2). 390–399. 7 indexed citations

Okazaki, Takahiro, Masaki Terabe, Andrew Catanzaro, et al.. (2006). Possible Therapeutic Vaccine Strategy against Human Immunodeficiency Virus Escape from Reverse Transcriptase Inhibitors Studied in HLA-A2 Transgenic Mice. Journal of Virology. 80(21). 10645–10651. 10 indexed citations

Carbone, David P., I. Frank Ciernik, Michael J. Kelley, et al.. (2005). Immunization With Mutantp53- andK-ras–Derived Peptides in Cancer Patients: Immune Response and Clinical Outcome. Journal of Clinical Oncology. 23(22). 5099–5107. 127 indexed citations

Okazaki, Takahiro, C D Pendleton, François A. Lemonnier, & Jay A. Berzofsky. (2003). Epitope-Enhanced Conserved HIV-1 Peptide Protects HLA-A2-Transgenic Mice Against Virus Expressing HIV-1 Antigen. The Journal of Immunology. 171(5). 2548–2555. 27 indexed citations

Ahlers, Jeffrey D., et al.. (1999). Approaches to improve engineered vaccines for human immunodeficiency virus and other viruses that cause chronic infections. Immunological Reviews. 170(1). 151–172. 80 indexed citations

Sarobe, Pablo, C D Pendleton, Toshitaka Akatsuka, et al.. (1998). Enhanced in vitro potency and in vivo immunogenicity of a CTL epitope from hepatitis C virus core protein following amino acid replacement at secondary HLA-A2.1 binding positions.. Journal of Clinical Investigation. 102(6). 1239–1248. 78 indexed citations

Alexander‐Miller, Martha A., Kenneth C. Parker, Taku Tsukui, et al.. (1996). Molecular analysis of presentation by HLA-A2.1 of a promiscuously binding V3 loop peptide from the HIV-1 envelope protein to human cytotoxic T lymphocytes. International Immunology. 8(5). 641–649. 32 indexed citations

10.

Ahlers, Jeffrey D., Nancy M. Dunlop, C D Pendleton, et al.. (1996). Candidate HIV Type 1 Multideterminant Cluster Peptide-P18MN Vaccine Constructs Elicit Type 1 Helper T Cells, Cytotoxic T Cells, and Neutralizing Antibody, All Using the Same Adjuvant Immunization. AIDS Research and Human Retroviruses. 12(4). 259–272. 39 indexed citations

11.

Shirai, Mutsunori, Kazutaka Kurokohchi, C D Pendleton, et al.. (1996). Reciprocal cytotoxic T lymphocyte cross-reactivity interactions between two major epitopes within HIV-1 gp160. The Journal of Immunology. 157(10). 4399–4411. 13 indexed citations

12.

Alexander‐Miller, Martha A., Kenneth C. Parker, Graham R. Leggatt, et al.. (1995). Similar presentation of a promiscuous HIV 1 peptide by human and murine class I MHC molecules, and ability of peptide induced murine CTL to clear virus infection in scid mice. AIDS Research and Human Retroviruses. 11. 1 indexed citations

13.

Shirai, Mutsunori, Hiroki Okada, Mikio Nishioka, et al.. (1994). An epitope in hepatitis C virus core region recognized by cytotoxic T cells in mice and humans. Journal of Virology. 68(5). 3334–3342. 127 indexed citations

14.

Shirai, Mutsunori, et al.. (1994). Helper-cytotoxic T lymphocyte (CTL) determinant linkage required for priming of anti-HIV CD8+ CTL in vivo with peptide vaccine constructs.. The Journal of Immunology. 152(2). 549–556. 157 indexed citations

15.

Kozlowski, Steven, Maripat Corr, Mutsunori Shirai, et al.. (1993). Multiple pathways are involved in the extracellular processing of MHC class I-restricted peptides.. The Journal of Immunology. 151(8). 4033–4044. 44 indexed citations

16.

Takahashi, Hidemi, Yohko Nakagawa, C D Pendleton, et al.. (1992). Induction of Broadly Cross-Reactive Cytotoxic T Cells Recognizing an HIV-1 Envelope Determinant. Science. 255(5042). 333–336. 119 indexed citations

17.

Kozlowski, Steven, Maripat Corr, Toshiyuki Takeshita, et al.. (1992). Serum angiotensin-1 converting enzyme activity processes a human immunodeficiency virus 1 gp160 peptide for presentation by major histocompatibility complex class I molecules.. The Journal of Experimental Medicine. 175(6). 1417–1422. 100 indexed citations

18.

Shirai, Mutsunori, C D Pendleton, & Jay A. Berzofsky. (1992). Broad recognition of cytotoxic T cell epitopes from the HIV-1 envelope protein with multiple class I histocompatibility molecules. The Journal of Immunology. 148(6). 1657–1667. 88 indexed citations

19.

Berzofsky, Jay A., C D Pendleton, Mario Clerici, et al.. (1991). Construction of peptides encompassing multideterminant clusters of human immunodeficiency virus envelope to induce in vitro T cell responses in mice and humans of multiple MHC types.. Journal of Clinical Investigation. 88(3). 876–884. 87 indexed citations

20.

Kim, Judy E., Richard A. Houghten, C D Pendleton, et al.. (1990). Characterization of a helper T cell epitope recognized by mice of a low responder major histocompatibility type. Molecular Immunology. 27(10). 941–946. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact